Do you have an innovative solution based on nanomedicine?

Apply for the Nanomedicine award 2015

The ETPN and the ENATRANS CSA have launched the second edition of the Nanomedicine Award to honour the best international nanomedicine innovations for 2015. The Award will be presented at the BIO-Europe conference in Munich in November 2015.

We strongly encourage to apply for the nanomedicine Awards 2015 by submitting their projects in both categories!

The application form is available online at nanomedicine-award.com

The goal of the Award is to promote and reward two excellent innovative nanomedicine-based solutions that could help physicians change the way diseases are treated and diagnosed, bringing significant benefits to patients.

The Award is open to companies as well as academic and private researchers across the globe. Nominated projects should be totally new diagnostic and therapeutic approaches that address unmet medical needs with nanomedicine, and have an explicit and defined potential market.

Nanomedicine proposals will be evaluated in two categories:
• Award for Best early clinical stage project
• Award for Best product or deal

Applications will be reviewed and assessed by a panel of highly-qualified industry experts with experience in R&D and business roles:
– Patrick Boisseau, Business Development Nanomedicine at CEA-Leti and President of the ETPN
– Patrick Tricoli, VP Corporate Development and CEO Nanobiotix Corp.
– Jeff Hrkach, formerly Chief Technology Officer of BIND Therapeutics, Inc. and member of the Nanomedicines Alliance
– Henry Havel, formerly Senior Research Fellow at Eli Lilly and Chairman of the Nanomedicines Alliance

The Award is supported by the EBD Group, the leading partnering firm for the global life science industry, the Nanomedicines Alliance, the US-based consortium dedicated to promoting and facilitating the scientific advancement, regulatory approval, and public appreciation of nanotechnology-based medicines and Nanobiotix, a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer.

The Award ceremony will take place during BIO-Europe 2015 in Munich (Germany) on the 3rd November 2015.

Winners will benefit from a full registration (including partnering) for BIO-Europe 2015 and a 10 minutes project presentation during the Conference. The winning projects will also be granted with a presentation during the ETPN General Assembly 2016, along with 1 year’s free ETPN membership and a consulting action by the experts from the Translation Advisory Board (TAB). The winners will gain visibility to EU decision makers from pharma industry, academia, finance and media.

Applications for the Award are open until 15th September 2015.The application form is available online at nanomedicine-award.com

Contacts

ENATRANS Coordinator
Nicolas GOUZE
ETPN Secretariat c/o VDI/VDE-IT
Nicolas.gouze@vdivde-it.de
Tel.: +49 30 310078 209

ENATRANS Communication
Sarah GAUBERT
Violaine EMOURGEON
sarah.gaubert@nanobiotix.com
violaine.emourgeon@nanobiotix.com
Tel.: + 33 1 75 44 69 42
SAVE THE DATE!
ETPN Annual Event 2015
Dublin, October 12th -14th 2015